Rhotekin contributes to osteoblast differentiation and bone homeostasis by interacting with Chibby 1

Area of Science:

• Cell Biology
• Molecular Biology
• Bone Biology

Background:

• Rhotekin is a Rho protein effector involved in tumorigenesis.
• Its role in other biological processes, including bone homeostasis, is largely unknown.

Purpose of the Study:

• To investigate the function of Rhotekin in osteoblast differentiation and bone homeostasis.
• To elucidate the molecular mechanisms underlying Rhotekin's role in bone biology.

Main Methods:

• Analysis of Rhotekin expression in bone and adipose tissue.
• Overexpression and knockdown studies in progenitor cells.
• In vivo silencing of Rhotekin in mouse bone marrow.
• Mechanistic studies involving protein-protein interactions and signaling pathway analysis (Wnt/β-catenin, FAK/AKT).

Main Results:

• Rhotekin expression increases during osteoblast and adipocyte differentiation.
• Rhotekin overexpression promotes osteogenesis and inhibits adipogenesis; knockdown has opposite effects.
• In vivo Rhotekin silencing reduces osteoblasts, increases adipocytes, and decreases bone mass.
• Rhotekin interacts with CBY1, displacing β-catenin and activating Wnt/β-catenin signaling.
• Rhotekin also activates the FAK/AKT pathway.

Conclusions:

• Rhotekin promotes osteoblast differentiation and bone homeostasis.
• It achieves this by interacting with CBY1 to activate the Wnt/β-catenin pathway and activating the FAK/AKT pathway.
• Rhotekin is a potential therapeutic target for metabolic bone disorders like osteoporosis.